NeuroPace (NPCE) Total Liabilities (2020 - 2026)
NeuroPace (NPCE) posted quarterly Total Liabilities of $84.4 million for Q1 2026, down 1.74% year-over-year from $85.9 million in Q1 2025, and down 2.42% quarter-over-quarter from $86.5 million in Q4 2025.
NeuroPace (NPCE) Total Liabilities (2020 - 2026) Analysis & Trends
NeuroPace's Total Liabilities history runs 7 years deep, the most recent figure standing at $84.4 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 1.74% year-over-year to $84.4 million; the TTM figure through Mar 2026 stood at $84.4 million (down 1.74% YoY), while the FY2025 annual figure was $86.5 million, changed 0.12% from the prior year.
- Total Liabilities for Q1 2026 stood at $84.4 million, down from $86.5 million in the prior quarter.
- The five-year high for Total Liabilities was $88.7 million in Q3 2025, with the low at $65.6 million in Q2 2022.
- The 5-year median for Total Liabilities is $84.5 million (2024), against an average of $81.9 million.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities jumped 32.09% in 2022, then decreased 1.74% in 2026.
- NeuroPace's Total Liabilities stood at $79.3 million in 2022, then rose by 9.67% to $87.0 million in 2023, then fell by 0.42% to $86.6 million in 2024, then slipped by 0.12% to $86.5 million in 2025, then slipped by 2.42% to $84.4 million in 2026.
- Business Quant data shows NPCE's Total Liabilities at $84.4 million in Q1 2026, $86.5 million in Q4 2025, and $88.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.51 Bn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 85.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 85.11 Mn |
| Mar 31, 2026 | 84.44 Mn |
| Dec 31, 2025 | 86.53 Mn |
| Sep 30, 2025 | 88.74 Mn |
| Jun 30, 2025 | 86.68 Mn |
| Mar 31, 2025 | 85.94 Mn |
| Dec 31, 2024 | 86.63 Mn |
| Sep 30, 2024 | 86.48 Mn |
| Jun 30, 2024 | 84.50 Mn |
| Mar 31, 2024 | 84.51 Mn |
| Dec 31, 2023 | 87.00 Mn |
| Sep 30, 2023 | 82.94 Mn |
| Jun 30, 2023 | 81.01 Mn |
| Mar 31, 2023 | 78.78 Mn |
| Dec 31, 2022 | 79.33 Mn |
| Sep 30, 2022 | 77.07 Mn |
| Jun 30, 2022 | 65.64 Mn |
| Mar 31, 2022 | 66.16 Mn |
| Dec 31, 2021 | 60.06 Mn |
| Sep 30, 2021 | 59.55 Mn |